{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 3746, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/4", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "key_messages", "function": "prioritize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/5", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/6", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart uses a stacked bar format to show both total revenue growth and the changing composition of product contributions over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/7", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-7", "loopMatches": [], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "other", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/8", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-8", "loopMatches": [ { "to": 13, "from": 8, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "63e5c157-0dc0-45b3-bd7c-a1f7052704eb", "evidence": "The deck presents growth trends and commercial performance of Alkermes' products.", "position": 2, "objective": "What do customers need?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.5, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "kpi_overview", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/9", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-9", "loopMatches": [ { "to": 13, "from": 8, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "63e5c157-0dc0-45b3-bd7c-a1f7052704eb", "evidence": "The deck presents growth trends and commercial performance of Alkermes' products.", "position": 2, "objective": "What do customers need?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.5, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a structured layout to present clinical outcomes alongside a study overview box.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/10", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-10", "loopMatches": [ { "to": 13, "from": 8, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "63e5c157-0dc0-45b3-bd7c-a1f7052704eb", "evidence": "The deck presents growth trends and commercial performance of Alkermes' products.", "position": 2, "objective": "What do customers need?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.5, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "kpi_overview", "function": "analyze_data", "notes": "Includes product branding and dosing regimen details.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/11", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-11", "loopMatches": [ { "to": 13, "from": 8, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "63e5c157-0dc0-45b3-bd7c-a1f7052704eb", "evidence": "The deck presents growth trends and commercial performance of Alkermes' products.", "position": 2, "objective": "What do customers need?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.5, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The chart shows a steady increase in annual net sales for VIVITROL.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/12", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-12", "loopMatches": [ { "to": 13, "from": 8, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "63e5c157-0dc0-45b3-bd7c-a1f7052704eb", "evidence": "The deck presents growth trends and commercial performance of Alkermes' products.", "position": 2, "objective": "What do customers need?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.5, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_takeaways", "function": "quantify_opportunity", "notes": "Includes disclaimer regarding patent litigation and definition of R12M.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/13", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-13", "loopMatches": [ { "to": 13, "from": 8, "name": "Voice Of Customer", "slug": "51-voice-of-customer", "bestFor": "Product strategy, customer experience, market research", "matchId": "63e5c157-0dc0-45b3-bd7c-a1f7052704eb", "evidence": "The deck presents growth trends and commercial performance of Alkermes' products.", "position": 2, "objective": "What do customers need?", "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response", "confidence": 0.5, "description": "Let customer quotes and feedback drive the narrative and validate the insight" } ], "arcBeatMatches": [ { "to": 13, "from": 4, "beatId": "5e80849a-633e-442e-8184-8e15f41fe45c", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Evidence", "beatSlug": "evidence", "evidence": "The deck presents evidence of Alkermes' growth trends and commercial performance.", "position": 1, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/14", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process flow diagram to illustrate the drug development lifecycle capabilities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/15", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "problem_statement", "function": "diagnose_problem", "notes": "Includes a medical illustration of brain pathways related to wakefulness and neurotransmitters.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/16", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-16", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 16, "from": 16, "beatId": "c1b0dfb9-8e00-407e-80d0-73d097a8aa29", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Complication", "beatSlug": "complication", "evidence": "The deck presents a problem statement on orexin dysfunction.", "position": 2, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "present_framework", "notes": "The chart is currently empty, serving as a framework template for future data plotting.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/17", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-17", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "other", "function": "analyze_data", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/18", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-18", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "present_framework", "notes": "The radar chart represents a multi-dimensional optimization framework for drug development.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/19", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-19", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "key_messages", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/20", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-20", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 23, "from": 20, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6855712d-cfcc-4ba8-90cd-9f606eb2639a", "evidence": "The deck presents results from ALKS 2680 clinical trials.", "position": 1, "objective": "What are the results of ALKS 2680?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Solution", "beatSlug": null, "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide features a screenshot of a conference poster or presentation title slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/21", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-21", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 23, "from": 20, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6855712d-cfcc-4ba8-90cd-9f606eb2639a", "evidence": "The deck presents results from ALKS 2680 clinical trials.", "position": 1, "objective": "What are the results of ALKS 2680?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Solution", "beatSlug": null, "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/22", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-22", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 23, "from": 20, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6855712d-cfcc-4ba8-90cd-9f606eb2639a", "evidence": "The deck presents results from ALKS 2680 clinical trials.", "position": 1, "objective": "What are the results of ALKS 2680?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Solution", "beatSlug": null, "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "other", "function": "present_solution", "notes": "The slide outlines a standard clinical trial protocol structure.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/23", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-23", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" }, { "to": 23, "from": 20, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "6855712d-cfcc-4ba8-90cd-9f606eb2639a", "evidence": "The deck presents results from ALKS 2680 clinical trials.", "position": 1, "objective": "What are the results of ALKS 2680?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Solution", "beatSlug": null, "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "other", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/24", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-24", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Solution", "beatSlug": null, "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "propose_solution", "function": "present_framework", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/25", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-25", "loopMatches": [ { "to": 25, "from": 16, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "58d89332-74ab-4a79-b132-80fa9e87fcdc", "evidence": "The deck presents a problem statement on orexin dysfunction and Alkermes' solution.", "position": 0, "objective": "What if Alkermes doesn't address orexin dysfunction?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 25, "from": 20, "beatId": "684f34f1-a86c-4f27-a384-190507ef00a2", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Solution", "beatSlug": null, "evidence": "The deck presents Alkermes' solution with ALKS 2680 and its development pipeline.", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/26", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 26, "beatId": "cc750d1d-b6ae-46eb-8f53-dc0fd48d268f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Resolution", "beatSlug": "resolution", "evidence": "The deck resolves with a discussion of sustained profitability and significant cash generation.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "kpi_overview", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/27", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-27", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 26, "beatId": "cc750d1d-b6ae-46eb-8f53-dc0fd48d268f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Resolution", "beatSlug": "resolution", "evidence": "The deck resolves with a discussion of sustained profitability and significant cash generation.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "key_messages", "function": "prioritize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/28", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-28", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 26, "beatId": "cc750d1d-b6ae-46eb-8f53-dc0fd48d268f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Resolution", "beatSlug": "resolution", "evidence": "The deck resolves with a discussion of sustained profitability and significant cash generation.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-8fd6-709e-8689-4f849e880c13", "docSlug": "045f5237a1062f1479093c113a295dbd", "documentTitle": "Alkermes | Investor Conference Presentation Deck | 29 slides", "authorId": "alkermes", "authorName": "Alkermes", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "closing_ask", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-8fd6-709e-8689-4f849e880c13/29", "deckHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13", "deckAnchorHref": "/decks/019de076-8fd6-709e-8689-4f849e880c13#slide-29", "loopMatches": [], "arcBeatMatches": [ { "to": 29, "from": 26, "beatId": "cc750d1d-b6ae-46eb-8f53-dc0fd48d268f", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Resolution", "beatSlug": "resolution", "evidence": "The deck resolves with a discussion of sustained profitability and significant cash generation.", "position": 4, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/VFsM7CM6AFwrGUn_J56LrpWrf4ytaZtROreXnr81Qho/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hODc3NmU3MTgzZTk2YTEwOWQxYTQ5MTQzZmMyZmY4OC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/1", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-1", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": "https://imgproxy.kitesheet.com/y-A-nQDfkXsaVYNm5eBgtSzkeitSai4mPG68yJBx3hI/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hODc3NmU3MTgzZTk2YTEwOWQxYTQ5MTQzZmMyZmY4OC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/vhbBrWtePY4sbY8P-6NCDUNlwX2_10_MBP9dfh_2RYw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hODc3NmU3MTgzZTk2YTEwOWQxYTQ5MTQzZmMyZmY4OC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/WnOOpdQy2a-0Z1_3qBMshplnWNWTMzo6k64TUqRRVsE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9hODc3NmU3MTgzZTk2YTEwOWQxYTQ5MTQzZmMyZmY4OC9wMDAxLnBuZw" }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/2", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-2", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a simple icon-based visual to anchor the core strategic goal.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/3", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-3", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "executive_summary", "function": "summarize", "notes": "The slide uses a structured grid layout to present high-level value propositions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/4", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-4", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a Gantt-style visualization to represent drug development stages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/5", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-5", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "context", "function": "establish_context", "notes": "The slide uses a four-column layout to structure the disease overview.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/6", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-6", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a map to show regional prevalence and a nested circle diagram to show the funnel from total infected to treated patients.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/7", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-7", "loopMatches": [ { "to": 7, "from": 7, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "cb04ba74-1ad4-41a8-8ee8-d093322ec7b3", "evidence": "The document highlights the unmet medical need.", "position": 0, "objective": "What is the cost of not addressing HBV?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.6, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 7, "from": 7, "beatId": "3adfa18e-bbfe-4577-8cc3-d51ef78ca459", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem", "beatSlug": "problem-agitate-solution-problem-identify-pain", "evidence": "The document identifies HBV as a significant unmet medical need.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" }, { "to": 7, "from": 7, "beatId": "48052fad-de34-4402-80d4-848fa58261ba", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Agitate", "beatSlug": "problem-agitate-solution-agitate-make-it-worse", "evidence": "The document highlights the limitations of current treatments.", "position": 1, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a process-oriented flow diagram to explain the therapeutic strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/8", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-8", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/9", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-9", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "solution", "function": "present_solution", "notes": "The slide highlights the mechanism of action and key benefits of the drug candidate.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/10", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-10", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "traction", "function": "analyze_data", "notes": "Data presented at EASL 2022, AASLD 2022, GHS 2023.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/11", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-11", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "traction", "function": "show_traction", "notes": "Data presented at EASL 2022. Shows dual-axis line charts for viral load/ALT and bar charts for T-cell frequency.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/12", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-12", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/13", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-13", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a clinical trial protocol with specific patient counts (n=12, n=8) and timeline milestones (weeks 1, 24, 28, 40, 52).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/14", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-14", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "traction", "function": "analyze_data", "notes": "Data presented at EASL 2023. Includes both a summary table of mean changes and individual patient trajectory charts.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/15", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-15", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "Shows two parallel study arms with randomization at week 24/26.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/16", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-16", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "appendix_data", "function": "analyze_data", "notes": "Data presented at AASLD 2023; includes both a summary table and a longitudinal line chart with error bars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/17", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-17", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "traction", "function": "show_traction", "notes": "Data presented at AASLD 2023. Shows ELISpot results for T cell responses and HBsAg levels.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/18", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-18", "loopMatches": [ { "to": 18, "from": 11, "name": "Quick Win Big Bet", "slug": "47-quick-win-big-bet", "bestFor": "Transformation planning, 100-day plans, resource allocation", "matchId": "9268b1b4-494b-44ee-8454-6a997fc0aa8b", "evidence": "The document presents clinical trial results and data.", "position": 1, "objective": "Can Imdusiran RNAi therapeutic and AB-101 oral PD-L1 inhibitor provide a quick win or a big bet for investors?", "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap", "confidence": 0.6, "description": "Separate initiatives into immediate wins and longer-term strategic bets" } ], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 18, "from": 11, "beatId": "bb704643-20a7-459a-9df1-5b5cea9225d9", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "The document presents clinical trial results and data.", "position": 3, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "traction", "function": "show_traction", "notes": "The slide details a specific licensing deal with Qilu Pharmaceutical, including financial terms and geographic scope.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/19", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "section_divider", "function": "transition", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/20", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-20", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "solution", "function": "present_solution", "notes": "The slide uses a three-column layout to explain the scientific basis and product advantages.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/21", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-21", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "traction", "function": "show_traction", "notes": "Includes both in vitro (IFN-y fold increase) and in vivo (MC38 tumor model) efficacy data.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/22", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-22", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "appendix_methodology", "function": "plan_implementation", "notes": "The slide outlines a multi-part clinical trial structure with specific cohort sizes and dosing progression.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/23", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-23", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "appendix", "function": "other", "notes": "Includes a footnote regarding the 3/21/2023 Court Scheduling Order.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/24", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-24", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "timeline", "function": "plan_implementation", "notes": "The slide includes a financial disclaimer regarding cash balance and burn.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/25", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-25", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 26, "from": 25, "beatId": "da1adf1d-15f4-4705-bfe7-3a2a4da5df9e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document outlines key milestones and a call to action.", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-906b-74a9-92f8-5c2872231d60", "docSlug": "a8776e7183e96a109d1a49143fc2ff88", "documentTitle": "Arbutus Biopharma | Investor Presentation Deck | 26 slides", "authorId": "arbutus-biopharma", "authorName": "Arbutus Biopharma", "documentKindSlug": "pitchdeck", "documentKindLabel": "Pitch deck", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "closing_ask", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-906b-74a9-92f8-5c2872231d60/26", "deckHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60", "deckAnchorHref": "/decks/019de076-906b-74a9-92f8-5c2872231d60#slide-26", "loopMatches": [], "arcBeatMatches": [ { "to": 26, "from": 8, "beatId": "b0891741-a256-4e4e-a8d2-65a9f9895b7f", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Solution", "beatSlug": "problem-agitate-solution-solution-provide-relief", "evidence": "The document presents Arbutus Biopharma's pipeline and clinical trial results as a solution.", "position": 2, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" }, { "to": 26, "from": 25, "beatId": "da1adf1d-15f4-4705-bfe7-3a2a4da5df9e", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "The document outlines key milestones and a call to action.", "position": 4, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": "https://imgproxy.kitesheet.com/smlp4Azd0Ahdg9W2wbvCnhJetplcWC2zXVpzsrlZMKo/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/1", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "cd56e8ef-e634-4e44-acce-3a6024b15bf6", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Introduction to argenx SE and its journey", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/2clKUcFxMrXoa78-DAEHgAawcL-1jTNAxV3ZOmYpEa8/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/ddq-h42um4yTZJRHJdpH22pNgogbxuA9jNIOIED65h8/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/XinXVMj_fmk7ej2zbBBYuuPS98YHqEBxTM9WtEruhVE/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy85M2MzNmNhMWY4OTc3YjNhNzBiNTY2Y2UwYWI1NDEzOC9wMDAxLnBuZw" }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "disclaimer", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/2", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "cd56e8ef-e634-4e44-acce-3a6024b15bf6", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Introduction to argenx SE and its journey", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "key_messages", "function": "present_framework", "notes": "The infinity loop suggests a continuous, self-reinforcing process of innovation.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/3", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 3, "from": 1, "beatId": "cd56e8ef-e634-4e44-acce-3a6024b15bf6", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Humble Origins", "beatSlug": "rags-to-riches-humble-origins", "evidence": "Introduction to argenx SE and its journey", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "testimonial", "function": "illustrate_case", "notes": "The slide uses a large portrait of a patient to build emotional connection and credibility.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/4", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "ad3dc0fe-411f-4efc-be3f-8dd150f1a6c0", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Discussion of challenges and innovation horizons", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "roadmap", "function": "present_framework", "notes": "Uses a concentric circle/horizon layout to represent different stages of development and commercialization.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/5", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-5", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "ad3dc0fe-411f-4efc-be3f-8dd150f1a6c0", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Discussion of challenges and innovation horizons", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "roadmap", "function": "plan_implementation", "notes": "The slide uses a circular/concentric layout to represent the 'horizon' of opportunities, with the pipeline on the left and commercial/development milestones on the right.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/6", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-6", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 6, "from": 4, "beatId": "ad3dc0fe-411f-4efc-be3f-8dd150f1a6c0", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Early Struggles", "beatSlug": "rags-to-riches-early-struggles", "evidence": "Discussion of challenges and innovation horizons", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses an infinity-loop style diagram to connect three pillars of leadership.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/7", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-7", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de076-9103-7399-8bed-9b1b1a8b182a", "docSlug": "93c36ca1f8977b3a70b566ce0ab54138", "documentTitle": "argenx SE | Investor Conference Presentation Deck | 27 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2024-01-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide highlights clinical outcomes (QoL, MG-ADL scores), treatment protocols (steroid tapering), patient support (My VYVGART Path), and economic value (cost/benefit vs IVIg).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de076-9103-7399-8bed-9b1b1a8b182a/8", "deckHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a", "deckAnchorHref": "/decks/019de076-9103-7399-8bed-9b1b1a8b182a#slide-8", "loopMatches": [ { "to": 14, "from": 5, "name": "Why Now", "slug": "15-why-now", "bestFor": "Sales pitches, fundraising, requesting immediate budget approval", "matchId": "f381209b-40fa-4c32-8920-66d6dea883b8", "evidence": "Discussion of innovation horizons and market opportunities", "position": 0, "objective": "Why now is the time for argenx SE's innovation", "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity", "confidence": 0.7, "description": "Create temporal urgency by proving that the window of opportunity is opening or closing" } ], "arcBeatMatches": [ { "to": 14, "from": 7, "beatId": "10300344-3ff1-4b97-95a5-8662d641a2aa", "arcName": "Rags to Riches", "arcSlug": "rags-to-riches", "beatName": "Rising Success", "beatSlug": "rags-to-riches-rising-success", "evidence": "Highlighting commercial execution and market opportunities", "position": 2, "confidence": 0.8, "parentBeatName": "Development", "parentBeatSlug": "development" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }